Epigenetic modification and characterization of the <i>MGMT</i> promoter region using CRISPRoff in glioblastoma cells
Remi Weber(University of Zurich), Flavio Vasella(University of Zurich)
Cited by 0
Related Papers
High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity
|Nature Medicine|2024|68
Targeting tumour-intrinsic neural vulnerabilities of glioblastoma
|bioRxiv (Cold Spring Harbor Laboratory)|2022|3
Epigenetic modification and characterization of the MGMT promoter region using CRISPRoff in glioblastoma cells
|Frontiers in Oncology|2024|3